ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
2016 · Annals of Oncology · 3,333 citations
https://doi.org/10.1093/annonc/mdw235
T
Tim Maughan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
635
Papers
20.2K
Citations
61
h-index
207
i10-index
Tim Maughan is an academic researcher from University of Liverpool. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Gastric Cancer Management and Outcomes & Genetic factors in colorectal cancer. The author has an h-index of 61, co-authored 540 publications.
ORCID: 0000-0002-0580-5065Papers by this author
worksPanitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
2013 · The Lancet Oncology · 388 citations
https://doi.org/10.1016/s1470-2045(13)70163-3
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
2019 · Nature Communications · 270 citations
https://doi.org/10.1038/s41467-019-09775-w
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
2011 · The Lancet Oncology · 262 citations
https://doi.org/10.1016/s1470-2045(11)70102-4
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
2011 · British Journal of Cancer · 168 citations
https://doi.org/10.1038/bjc.2011.240
The evolutionary landscape of colorectal tumorigenesis
2018 · Nature Ecology & Evolution · 148 citations
https://doi.org/10.1038/s41559-018-0642-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat